Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

West Pharmaceutical Services (WST - Snapshot Report) recently increased its quarterly cash dividend by 1 cent per share to 19 cents per share, beginning in the fourth quarter of 2012. The increased dividend will be paid on November 7, 2012, to stockholders of record as of October 24, 2012.

The announcement marks the nineteenth successive annual increase in West Pharmaceutical’s quarterly dividend. The company’s commitment to returning wealth to its shareholders reflects the strength of its cash generation capabilities.

West Pharmaceutical is characterized by a capital structure which generates adequate liquidity to fund research and development expenditure and pay dividends. Innovation at West Pharmaceutical is backed by high research and development, with associated expenditure seen as imperative for maintenance of competitive advantage. The increase in dividend should boost investor confidence and drive share value.

West Pharmaceutical, which has ascended in price as of late, currently has a dividend yield of 1.4% and a payout ratio of 26.3%. Based on these metrics and the revision of 2012 earnings guidance to a range of $2.60 to $2.70, up from $2.50 to $2.67, the company is adequately placed to generate lucrative returns to shareholders.

West Pharmaceutical, which competes with 3M Co. (MMM - Analyst Report) and Rexam plc. (REXMY) in certain niches, currently has a short-term Zacks #2 Rank (Buy rating). The company, a global leader in the provision of drug administration systems and components for packaging as well as delivery of injectable drugs and delivery system components across various industries, has a significant competitive advantage in the market it serves.

Additionally, it continues to make headway into new geographies to expand its business. The company opened two new plants in China and India in an effort to meet the dynamic and burgeoning market demand, especially in the Asia-Pacific region. However, macroeconomic pressure across the globe remains a headwind.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
LAKE SHORE G LSG 0.77 +6.05%
QUESTCOR PHA QCOR 80.07 +2.47%
VIPSHOP HOLD VIPS 156.35 +1.82%
ENLINK MIDST ENLC 36.29 +1.60%
BNC BANCORP BNCN 17.33 +1.58%